Smart, innovative, digital: where progressive pharma companies achieve ambitious new objectives

Back for it’s 13th year: Attend the event where Commercial, Medical, RWE and Clinical transformation will be determined

eyeforpharma Japan 2020 is where you will decide your future. The healthcare landscape is evolving and pharma must evolve with it. That’s why we have ensured that our agenda features great insights on how to achieve high effectiveness with limited time and resources. Sometimes this involves digitizing existing processes, sometimes it involves forming new partnerships and sometimes it requires imaginative new business models. We will also provide great case studies from industry leaders and plenty of networking time.

From the Opening Keynote, focusing on future direction of pharma with cutting-edge case studies, to the practical tracks covering Clinical Innovation, Commercial Excellence, Medical Affairs & RWE, we will deliver a new direction for your planning.

Be part of the movement to evolve Japan’s pharma industry!

eyeforpharma Japan is a valuable platform for our industry to network, exchange views and anticipate our industry trends and evolution.

Alexandre de Muralt, Representative Director and President, Merck Biopharma Co., Ltd. Merck  Logo Alexandre de Muralt Headshot

World-class speaker faculty includes:

Taro Ueno - Headshot
SUSMED Inc. - Logo

Taro Ueno CEO SUSMED Inc.

Stefan Sakurai - Headshot
LEO Pharma - Logo

Stefan Sakurai President / Japan Representative Director LEO Pharma

Masatsune Okajima - Headshot
StemRIM - Logo

Masatsune Okajima President and COO StemRIM

Hiroyuki Yoshihara - Headshot
Life Data Initiative, Japan - Logo

Hiroyuki Yoshihara Representative Director Life Data Initiative, Japan Emeritus Professor Kyoto University and University of Miyazaki, Japan

Eiji Aramaki - Headshot
NAIST Graduate School of Science and Technology - Logo

Eiji Aramaki Associate Professor, PI, Information Science NAIST Graduate School of Science and Technology

Jovelle L. Fernandez - Headshot
Takeda - Logo

Jovelle L. Fernandez Head Japan Medical Office Takeda

Susie Barnes - Headshot
GlaxoSmithKline Japan - Logo

Susie Barnes Vice President and Country Medical Director GlaxoSmithKline Japan

Kentaro Kume - Headshot
Takeda Pharmaceutical Company Limited - Logo

Kentaro Kume Head, R&D Partnership Office Asia Pacific Takeda Pharmaceutical Company Limited

David Hernandez - Headshot
Merck Biopharma Co., Ltd. - Logo

David Hernandez Head of Clinical Operations Japan, Global Clinical Operations Merck Biopharma Co., Ltd.

Haider Alleg - Headshot
Ferring Pharmaceuticals - Logo

Haider Alleg Global Head of Digital Excellence Ferring Pharmaceuticals

Debraj Dasgupta - Headshot
Nippon Boehringer Ingelheim Co., Ltd. - Logo

Debraj Dasgupta Operating Officer, Head of Strategy and GTM Planning Division Nippon Boehringer Ingelheim Co., Ltd.

Naohiro Yonemoto - Headshot
Pfizer - Logo

Naohiro Yonemoto Director, Patient Impact Analysis, Outcome & Evidence,
Corporate affairs, Health & Value

4 essential themes for 2020

Digital transformation: Transform your business model by ensuring you act decisively on customer insights. Recognize the need to digitize. Focus on value with partnerships that deliver holistic patient outcomes.

Evidence-led leadership: Generate great evidence through data. Ensure its communicated well to improve decision-making, portfolio design, patient recruitment and better, medically-driven content.

Deliver patient value to drive commercial & medical excellence: Prove the authenticity of your medicine and care provision with robust data and a great story for HCPs and patient outcomes.

Make Japan a clinical powerhouse: See how data and digital technology can cut costs and time in clinical development. Drive a more patient-centric approach in development to ensure Japan becomes the world's best place to run innovative clinical trials.

Delivered through 4 business-critical tracks

Keynote Get out of your comfort zone and explore the new frontiers of medicine from the ‘digital twin’ to advanced genomics, digital therapeutics, AI and more.

Learn more about this track

Commercial Excellence A new commercial model is needed to effectively deliver digital transformation. Use technology to provide deeper value to physicians and even patients.

Learn more about this track

RWE & Medical: Make trust your most important principle by communicating in an authentic, scientific way, backed by evidence. Use RWE to speed development, widen access and boost patient outcomes.

Learn more about this track

Clinical Innovation: Cut time and cost through new technology, whilst enabling a more patient-centric approach which boosts recruitment and retention. Recognize that smarter clinical trials could unlock a golden era for pharma.

Learn more about this track

Key features of eyeforpharma Japan

4 business-critical conference streams

eyeforpharma Japan will cover all key topics with four tracks: Keynote, Clinical Innovation, RWE & Medical and Commercial Excellence. Which means you’ll gain insights which will help drive your business.


Network with over 500 attendees in 15+ hours of dedicated networking time, networking events and interactive sessions.

All stakeholders. All functions. 1 Place.

The most cross-functional pharma event in Japan – decision-makers from marketing, commercial, sales, market access, medical affairs, patient engagement, RWE, digital transformation, IT, clinical and more.

The most senior-level pharma event in Japan

You won’t find a better place to meet your peers since over 80% of the pharma attendees are director-level or above.

Find the solution

Sometimes, the best ideas don’t come from the stage. They come from those chance happenings when you join a roundtable or attend a networking evening. eyeforpharma is packed with opportunities for you to connect with prospective collaborators and idea generators.

Drive the future

Experts and thought leaders will share cutting edged case studies. Re-position your strategy and teams aligned to the industry’s next movement.

eyeforpharma Japan is a useful platform to be informed about recent trends in pharma industry.

Jovelle L. Fernandez, MD, PhD, FPOGS, Head, Japan Medical Office, Takeda Pharmaceutical Company Headshot

An action-packed timetable

Attended by pharma and health innovators from:

sandoz's Logo
ViiV Healthcare's Logo
johnson_johnson's Logo
boehringer_ingelheim's Logo

bms's Logo
gilead's Logo

allergan's Logo
UCB's Logo

astra_zeneca's Logo
roche's Logo

kyoto_university's Logo
pfizer's Logo

takeda's Logo
tokyo_medical_and_dental_university's Logo
novartis's Logo
amicus's Logo

merck_darkerblue's Logo
sanofi's Logo

janssen's Logo
bayer's Logo

novo_nordisk's Logo
csl's Logo
biogen's Logo
LEO Pharma's Logo

nestle's Logo
abbvie's Logo
astellas_amgen_biopharma's Logo
transcelerate's Logo

university_of_tokyo's Logo
EFPIA's Logo

chugai_no_roche's Logo
msd's Logo

shionogi's Logo
amed's Logo
Eisai's Logo
gsk_logo's Logo

astellas's Logo
lilly's Logo
otsuka_us's Logo
Daiichi Sankyo's Logo

You won’t find your next idea at home. Make the most of the networking with:

500+ networkers Key decision-makers in Japanese pharma

10+ hours
of networking

Total interaction Roundtables, workshops and panel discussions

Real decision-makers

Other events say they attract senior executives - people with clout, budget, ideas and a mission. We really mean it. 500 of them.

77% of attendees are director-level and above

Real diversity

eyeforpharma Japan attracts a global audience: a variety of job titles, geographies, cultures and opinions create a rich tapestry.

Here to help

Get in touch with the eyeforpharma team

Paul Simms Headshot

Paul Simms Chairman

Blair Gottscho Headshot

Blair Gottscho VP Operations

Kana Chia Headshot

Kana Chia Head of Japan

Akari Ueda Headshot

Akari Ueda Project Director, Japan

Hiromasa Araki Headshot

Hiromasa Araki Business Development Executive

Ross McMullan Headshot

Ross McMullan Business Development Director